Want a similar experience
Sposito AC, Berwanger O, de Carvalho LS, Saraiva JF
Razia Hashmi, vice president of clinical affairs for the Blue Cross Blue Shield Association
GLP-1 and GIP can decelerate gastric emptying, thus moderating the rate of nutrient absorption and aiding glycemic control
For researchers interested in the comparison between tirzepatide and next-generation compounds like retatrutide, which adds a third receptor (GCG), our guide to retatrutide versus semaglutide provides useful context, as does our three-way comparison of semaglutide, tirzepatide, and retatrutide
Patients discontinuing GLP-1 medications should monitor for signs of gallbladder problems (severe abdominal pain, especially after meals), pancreatitis (persistent severe abdominal pain, sometimes with vomiting), or significant hyperglycemia